Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $10.07 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.06.
Market Cap
10.07T
Revenue
4.74T
Profits
213.91B
PE Ratio
47.06
Profit Margin
4.51%
Dividend Yield
0.37%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.29T | 1.26% | 2,084,332 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 687.89B | 0.79% | 6,291,245 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 521.50B | 0.20% | 3,262,105 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.09B | 0.58% | 3,472,018 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 364.26B | 0.55% | 6,507,620 | 67.38B |
| 6 | NVS | Novartis AG | 302.07B | 0.16% | 1,417,486 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 286.76B | 0.04% | 1,850,948 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 259.44B | 0.11% | 1,837,421 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.89B | -0.30% | 2,122,317 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 208.48B | 0.08% | 3,626,545 | 30.99B |
| 11 | ABT | Abbott Laboratories | 187.95B | 1.18% | 6,199,913 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 181.25B | 2.41% | 11,714,402 | 50.70B |
| 13 | PFE | Pfizer Inc. | 164.67B | 0.21% | 21,598,787 | 63.62B |
| 14 | DHR | Danaher Corporation | 163.94B | 0.37% | 3,359,510 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 153.77B | 0.84% | 1,604,247 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 136.56B | -0.74% | 756,204 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.66B | 1.78% | 9,274,362 | 50.03B |
| 18 | MCK | McKesson Corporation | 127.33B | 2.39% | 527,485 | 418.79B |
| 19 | MDT | Medtronic plc | 125.91B | 1.85% | 5,257,515 | 37.54B |
| 20 | SYK | Stryker Corporation | 117.88B | -0.88% | 3,251,980 | 26.30B |
| 21 | SNY | Sanofi | 115.81B | -0.19% | 1,675,937 | 57.89B |
| 22 | CVS | CVS Health Corporation | 114.32B | -0.49% | 8,019,872 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.25B | -0.32% | 971,110 | 78.70B |
| 24 | GSK | GSK plc | 101.33B | 0.51% | 2,781,492 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 95.88B | 0.45% | 1,165,614 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 92.84B | -0.05% | 779,120 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 90.38B | -3.45% | 8,085,639 | 2.53B |
| 28 | CI | The Cigna Group | 78.26B | 0.25% | 1,442,196 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 69.20B | 1.47% | 3,751,438 | 29.86B |
| 30 | COR | Cencora, Inc. | 68.51B | 2.96% | 1,393,218 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.97B | 1.06% | 1,261,649 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 64.27B | 0.32% | 9,700,014 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 61.61B | 1.28% | 3,822,367 | 6.67B |
| 34 | ARGX | argenx SE | 60.62B | -2.17% | 225,890 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 59.39B | 1.08% | 1,879,895 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.48B | 0.89% | 392,153 | 4.66B |
| 37 | HUM | Humana Inc. | 54.05B | 1.42% | 1,520,562 | 154.19B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 51.92B | 1.95% | 7,562,853 | 17.23B |
| 39 | MDLN | Medline Inc. | 51.92B | -1.28% | 8,434,194 | 30.68B |
| 40 | A | Agilent Technologies, Inc. | 49.04B | 0.55% | 1,415,208 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 48.82B | -0.29% | 750,244 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.58B | 0.14% | 345,436 | 6.45B |
| 43 | NTRA | Natera, Inc. | 46.27B | -1.19% | 1,690,788 | 2.91B |
| 44 | WAT | Waters Corporation | 45.24B | -0.42% | 521,853 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 43.69B | -2.21% | 1,986,079 | 17.31B |
| 46 | HLN | Haleon plc | 40.09B | 0.88% | 16,105,639 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.76B | 0.84% | 2,951,369 | 2.62B |
| 48 | GEHC | GE HealthCare Technologies Inc. | 37.54B | 1.44% | 2,394,985 | 21.64B |
| 49 | BIIB | Biogen Inc. | 37.46B | 1.17% | 1,028,880 | 10.30B |
| 50 | RVMD | Revolution Medicines, Inc. | 37.27B | -2.30% | 2,654,234 | 197.56M |
| 51 | CNC | Centene Corporation | 35.28B | 1.42% | 4,017,765 | 180.41B |
| 52 | ALC | Alcon Inc. | 35.17B | 3.19% | 2,787,188 | 10.98B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.59B | 0.46% | 142,677 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 34.06B | 1.04% | 3,152,385 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.69B | 0.27% | 853,189 | 5.73B |
| 56 | GMAB | Genmab A/S | 32.22B | -0.72% | 3,733,328 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 31.30B | -1.21% | 1,229,533 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 31.08B | 2.38% | 2,975,116 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.08B | -0.49% | 488,973 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.59B | 0.97% | 1,341,121 | 20.16B |
| 61 | WST | West Pharmaceutical Services, Inc. | 29.01B | 1.24% | 479,116 | 3.40B |
| 62 | ROIV | Roivant Sciences Ltd. | 28.64B | -1.15% | 7,194,763 | 41.08M |
| 63 | DGX | Quest Diagnostics Incorporated | 28.56B | -0.02% | 649,384 | 11.84B |
| 64 | INSM | Insmed Incorporated | 26.58B | 2.62% | 1,543,587 | 1.52B |
| 65 | STE | STERIS plc | 25.67B | 4.29% | 984,383 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 25.18B | -0.36% | 446,806 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.66B | -0.60% | 950,495 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.87B | 0.73% | 6,514,717 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.76B | -0.29% | 372,745 | 22.15B |
| 70 | ALNY | Alnylam Pharmaceuticals, Inc. | 22.11B | 5.36% | 3,589,970 | 5.01B |
| 71 | BNTX | BioNTech SE | 21.22B | 0.66% | 844,753 | 2.75B |
| 72 | GH | Guardant Health, Inc. | 20.52B | -2.04% | 1,293,355 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.53B | -1.29% | 2,518,677 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.29B | -0.44% | 105,444 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 18.06B | 3.12% | 826,058 | 1.37B |
| 76 | RVTY | Revvity, Inc. | 17.24B | -1.67% | 1,306,669 | 2.94B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.94B | -1.18% | 1,380,856 | 3.70B |
| 78 | EXEL | Exelixis, Inc. | 16.84B | -1.20% | 1,522,001 | 2.50B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.19B | -0.83% | 838,318 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.50B | 0.49% | 496,698 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.25B | 0.17% | 1,149,255 | 945.54M |
| 82 | SOLV | Solventum Corporation | 15.12B | 0.30% | 917,957 | 8.16B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 14.83B | -0.34% | 1,347,160 | 15.25B |
| 84 | ICLR | ICON Public Limited Company | 14.58B | -2.92% | 966,540 | 8.23B |
| 85 | GKOS | Glaukos Corporation | 14.54B | -0.13% | 546,460 | 690.33M |
| 86 | EHC | Encompass Health Corporation | 13.83B | 0.11% | 502,865 | 6.34B |
| 87 | ELAN | Elanco Animal Health Incorporated | 13.39B | 1.06% | 5,378,798 | 5.15B |
| 88 | BAX | Baxter International Inc. | 13.35B | 0.27% | 4,491,218 | 11.61B |
| 89 | TEM | Tempus AI, Inc. | 13.06B | -5.65% | 5,306,625 | 1.51B |
| 90 | SNN | Smith & Nephew plc | 13.02B | 0.90% | 1,365,149 | 6.30B |
| 91 | PEN | Penumbra, Inc. | 12.65B | 0.04% | 237,595 | 1.56B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 12.17B | 0.07% | 3,713,807 | 3.44B |
| 93 | COO | The Cooper Companies, Inc. | 11.91B | 0.74% | 1,574,266 | 4.24B |
| 94 | ALGN | Align Technology, Inc. | 11.86B | 0.81% | 665,710 | 4.16B |
| 95 | FMS | Fresenius Medical Care AG | 11.49B | 1.99% | 1,349,801 | 22.12B |
| 96 | TECH | Bio-Techne Corporation | 11.44B | 0.05% | 2,491,009 | 1.23B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.43B | -0.40% | 2,276,409 | 1.80B |
| 98 | SMMT | Summit Therapeutics Inc. | 11.32B | -6.17% | 5,555,312 | - |
| 99 | UHS | Universal Health Services, Inc. | 11.19B | 0.12% | 448,255 | 18.35B |
| 100 | MTRI | Mentari Therapeutics, Inc. | 11.18B | 1.36% | 11,913 | - |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.09B | 0.93% | 1,466,196 | 3.66B |
| 102 | DVA | DaVita Inc. | 10.98B | 0.28% | 671,147 | 14.17B |
| 103 | MOH | Molina Healthcare, Inc. | 10.91B | -0.17% | 363,199 | 42.08B |
| 104 | ENSG | The Ensign Group, Inc. | 10.90B | 1.00% | 254,730 | 5.67B |
| 105 | KYMR | Kymera Therapeutics, Inc. | 10.89B | 0.31% | 808,713 | 102.24M |
| 106 | RGEN | Repligen Corporation | 10.73B | 0.76% | 510,106 | 805.61M |
| 107 | PODD | Insulet Corporation | 10.58B | 2.14% | 1,590,978 | 3.19B |
| 108 | AVTR | Avantor, Inc. | 10.53B | -0.51% | 6,819,433 | 6.64B |
| 109 | QGEN | Qiagen N.V. | 10.30B | -0.42% | 1,642,137 | 2.12B |
| 110 | PCVX | Vaxcyte, Inc. | 10.03B | -2.04% | 623,598 | - |
| 111 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.93B | 0.51% | 441,233 | 1.43B |
| 112 | SYRE | Spyre Therapeutics, Inc. | 9.88B | 1.06% | 746,232 | - |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.85B | -1.11% | 256,211 | 2.59B |
| 114 | OSCR | Oscar Health, Inc. | 9.64B | -2.79% | 4,847,354 | 17.47B |
| 115 | GMED | Globus Medical, Inc. | 9.56B | -0.22% | 1,549,142 | 3.14B |
| 116 | HSIC | Henry Schein, Inc. | 9.53B | 0.09% | 2,184,650 | 13.73B |
| 117 | BRKR | Bruker Corporation | 9.41B | 2.09% | 2,020,980 | 3.51B |
| 118 | HNGE | Hinge Health, Inc. | 9.38B | -4.63% | 1,482,300 | 800.82M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.17B | 1.04% | 352,864 | 7.46M |
| 120 | ATR | AptarGroup, Inc. | 9.07B | 0.97% | 546,911 | 3.99B |
| 121 | KRYS | Krystal Biotech, Inc. | 9.05B | -0.15% | 110,280 | 470.03M |
| 122 | TGTX | TG Therapeutics, Inc. | 9.04B | -0.08% | 1,095,871 | 897.76M |
| 123 | HQY | HealthEquity, Inc. | 8.56B | 0.40% | 565,301 | 1.36B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -2.55% | 759,906 | 551.69M |
| 125 | CORT | Corcept Therapeutics Incorporated | 7.98B | -1.04% | 1,112,931 | 963.65M |
| 126 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.97B | 4.70% | 1,158,733 | 280.75M |
| 127 | ALKS | Alkermes plc | 7.90B | 0.11% | 1,429,845 | 1.75B |
| 128 | CYTK | Cytokinetics, Incorporated | 7.82B | -0.05% | 1,013,555 | 113.29M |
| 129 | GRFS | Grifols, S.A. | 7.68B | -1.25% | 312,611 | 8.63B |
| 130 | PACS | PACS Group, Inc. | 7.67B | 0.67% | 464,464 | 5.71B |
| 131 | TXG | 10x Genomics, Inc. | 7.65B | -1.54% | 2,125,516 | 618.58M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.61B | -2.90% | 698,950 | 5.33M |
| 133 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.57B | 0.05% | 465,594 | 945.96M |
| 134 | BLCO | Bausch + Lomb Corporation | 7.54B | -0.24% | 525,920 | 5.42B |
| 135 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.86% | 973,045 | 865.27M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.45B | -1.47% | 1,717,834 | 3.20B |
| 137 | KOD | Kodiak Sciences Inc. | 7.26B | 2.72% | 972,129 | - |
| 138 | ORKA | Oruka Therapeutics, Inc. | 7.15B | 0.34% | 679,676 | - |
| 139 | CHE | Chemed Corporation | 7.10B | -0.36% | 73,524 | 2.66B |
| 140 | IMVT | Immunovant, Inc. | 7.07B | -2.48% | 864,838 | - |
| 141 | TWST | Twist Bioscience Corporation | 7.00B | -2.29% | 2,046,248 | 459.43M |
| 142 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.75B | 1.34% | 3,113,428 | 450.82M |
| 143 | CGON | CG Oncology, Inc. | 6.65B | 6.06% | 3,238,514 | 6.17M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.64B | 0.34% | 758,035 | 1.56B |
| 145 | BLTE | Belite Bio, Inc | 6.62B | -3.30% | 216,974 | - |
| 146 | CAI | Caris Life Sciences, Inc. | 6.61B | -3.84% | 3,021,304 | 1.05B |
| 147 | IBRX | ImmunityBio, Inc. | 6.40B | -0.82% | 13,331,736 | 182.57M |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.18B | -2.37% | 135,759 | 253.83M |
| 149 | SUPN | Supernus, Inc. | 6.17B | 1.78% | 2,071,608 | 1.37B |
| 150 | TFX | Teleflex Incorporated | 6.15B | 1.27% | 836,397 | 2.26B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 0.71% | 331,054 | 670.78M |
| 152 | RDNT | RadNet, Inc. | 6.02B | 0.50% | 476,239 | 2.38B |
| 153 | DOCS | Doximity, Inc. | 5.95B | 0.42% | 1,395,931 | 661.58M |
| 154 | HAE | Haemonetics Corporation | 5.60B | 0.19% | 439,696 | 1.38B |
| 155 | ERAS | Erasca, Inc. | 5.50B | -0.76% | 8,533,403 | - |
| 156 | MANE | Veradermics, Incorporated | 5.47B | -4.16% | 938,026 | - |
| 157 | WAY | Waystar Holding Corp. | 5.39B | -0.53% | 1,147,520 | 1.26B |
| 158 | CON | Concentra Group Holdings Parent, Inc. | 5.38B | -1.02% | 582,526 | 2.34B |
| 159 | LFST | LifeStance Health Group, Inc. | 5.35B | -0.49% | 3,728,905 | 1.68B |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.30B | 0.21% | 502,867 | 1.16B |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.27B | 0.10% | 623,481 | 570.00K |
| 162 | GRAL | GRAIL, Inc. | 5.21B | -4.50% | 359,739 | 166.60M |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.19B | -0.07% | 421,764 | 1.61B |
| 164 | LQDA | Liquidia Corporation | 5.17B | -1.22% | 1,933,017 | 621.87M |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 5.17B | -0.72% | 681,518 | 2.72M |
| 166 | MMED | MiniMed Group, Inc. | 5.06B | 0.64% | 5,376,894 | 3.22B |
| 167 | LIVN | LivaNova PLC | 5.03B | 1.24% | 742,274 | 1.51B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 5.03B | 0.24% | 1,162,441 | - |
| 169 | BLLN | BillionToOne, Inc. | 5.02B | -5.09% | 672,185 | 436.87M |
| 170 | COGT | Cogent Biosciences, Inc. | 4.97B | -1.99% | 1,150,743 | - |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.86B | -1.76% | 708,197 | 651.03M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.84B | 6.41% | 5,948,628 | 960.09M |
| 173 | SHC | Sotera Health Company | 4.74B | 1.90% | 2,647,528 | 1.23B |
| 174 | OPCH | Option Care Health, Inc. | 4.74B | -0.09% | 1,866,342 | 5.75B |
| 175 | ADPT | Adaptive Biotechnologies Corporation | 4.70B | -1.49% | 2,063,762 | 298.01M |
| 176 | HIMS | Hims & Hers Health, Inc. | 4.62B | 0.00% | 10,068,634 | 2.87B |
| 177 | ICUI | ICU Medical, Inc. | 4.48B | 1.11% | 195,453 | 2.18B |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.39B | -2.79% | 778,178 | - |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.32B | 2.62% | 2,677,674 | 53.81M |
| 180 | STVN | Stevanato Group S.p.A. | 4.32B | 10.03% | 1,458,041 | 1.42B |
| 181 | ITGR | Integer Holdings Corporation | 4.31B | 0.22% | 966,699 | 1.83B |
| 182 | HTFL | HeartFlow, Inc. | 4.26B | -19.13% | 3,705,631 | 238.66M |
| 183 | CRSP | CRISPR Therapeutics AG | 4.10B | -0.89% | 1,873,738 | 25.17M |
| 184 | CDNA | CareDx, Inc. | 4.09B | -2.42% | 716,919 | 497.40M |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.00B | 0.06% | 1,478,162 | 10.35M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.98B | -1.27% | 607,633 | 7.50M |
| 187 | TARS | Tarsus Pharmaceuticals, Inc. | 3.96B | 4.41% | 732,091 | 682.20M |
| 188 | NVST | Envista Holdings Corporation | 3.93B | -0.69% | 1,793,407 | 2.88B |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.89B | 1.44% | 1,618,681 | -665.00K |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.73B | 5.95% | 8,870,652 | - |
| 191 | ABCL | AbCellera Biologics Inc. | 3.72B | -1.12% | 2,677,637 | 67.85M |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.71B | -3.46% | 590,839 | 1.49M |
| 193 | OGN | Organon & Co. | 3.65B | 0.00% | 3,999,230 | 6.10B |
| 194 | IRON | Disc Medicine, Inc. | 3.64B | -3.88% | 779,944 | - |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.59B | 1.01% | 972,559 | - |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.59B | 1.70% | 11,675,067 | 378.98M |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.57B | 2.65% | 858,150 | 508.68M |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.56B | 2.67% | 555,139 | 2.26M |
| 199 | ACHC | Acadia Healthcare Company, Inc. | 3.51B | -0.08% | 2,502,828 | 3.41B |
| 200 | VRDN | Viridian Therapeutics, Inc. | 3.51B | 1.28% | 1,204,162 | 26.31M |
| 201 | SGRY | Surgery Partners, Inc. | 3.49B | 1.39% | 3,138,803 | 3.36B |
| 202 | WRBY | Warby Parker Inc. | 3.41B | 2.66% | 2,480,340 | 934.66M |
| 203 | LEGN | Legend Biotech Corporation | 3.39B | -5.61% | 3,029,717 | 1.36B |
| 204 | AXGN | Axogen, Inc. | 3.34B | 0.96% | 1,380,323 | 266.93M |
| 205 | NHC | National HealthCare Corporation | 3.26B | -1.35% | 74,493 | 1.58B |
| 206 | ACAD | Acadia Pharmaceuticals Inc. | 3.24B | 3.36% | 1,785,340 | 1.20B |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.22B | 0.88% | 1,674,443 | - |
| 208 | TMDX | TransMedics Group, Inc. | 3.17B | -0.67% | 840,806 | 727.65M |
| 209 | CELC | Celcuity Inc. | 3.16B | 0.31% | 646,496 | - |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 3.14B | 0.28% | 339,071 | 1.46B |
| 211 | PRVA | Privia Health Group, Inc. | 3.14B | 3.72% | 1,608,770 | 2.43B |
| 212 | TLX | Telix Pharmaceuticals Limited | 3.13B | -1.39% | 110,831 | 890.79M |
| 213 | BHC | Bausch Health Companies Inc. | 3.13B | 1.21% | 2,340,005 | 11.11B |
| 214 | IRTC | iRhythm Holdings, Inc. | 3.09B | -1.76% | 917,820 | 854.04M |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 1.08% | 778,653 | 36.54M |
| 216 | XERS | Xeris Biopharma Holdings, Inc. | 3.04B | 0.06% | 3,399,051 | 368.26M |
| 217 | ADMA | ADMA Biologics, Inc. | 3.03B | 3.32% | 4,160,093 | 519.15M |
| 218 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.79% | 795,667 | 21.38M |
| 219 | VCEL | Vericel Corporation | 2.91B | -0.80% | 698,760 | 324.17M |
| 220 | ATRC | AtriCure, Inc. | 2.89B | 1.54% | 558,767 | 589.80M |
| 221 | XNCR | Xencor, Inc. | 2.78B | -2.73% | 958,131 | 200.49M |
| 222 | MBX | MBX Biosciences, Inc. | 2.78B | 2.62% | 855,453 | - |
| 223 | ZLAB | Zai Lab Limited | 2.77B | -5.53% | 1,224,326 | 441.73M |
| 224 | PGNY | Progyny, Inc. | 2.66B | -1.09% | 869,007 | 1.34B |
| 225 | CLOV | Clover Health Investments, Corp. | 2.66B | 1.64% | 4,778,745 | 2.74B |
| 226 | HCM | HUTCHMED (China) Limited | 2.55B | 0.34% | 22,857 | 549.12M |
| 227 | AVAH | Aveanna Healthcare Holdings Inc. | 2.51B | -6.05% | 4,266,614 | 2.68B |
| 228 | RCUS | Arcus Biosciences, Inc. | 2.51B | -1.91% | 1,138,756 | 100.00M |
| 229 | ARDT | Ardent Health, Inc. | 2.51B | 0.68% | 779,516 | 6.45B |
| 230 | NEOG | Neogen Corporation | 2.45B | 0.36% | 1,802,179 | 884.00M |
| 231 | RGC | Regencell Bioscience Holdings Limited | 2.45B | -3.70% | 119,338 | - |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.42B | 0.85% | 1,674,201 | 25.94M |
| 233 | MD | Pediatrix Medical Group, Inc. | 2.38B | -0.32% | 468,055 | 1.96B |
| 234 | UFPT | UFP Technologies, Inc. | 2.36B | -0.28% | 65,170 | 649.52M |
| 235 | PHVS | Pharvaris N.V. | 2.34B | -1.39% | 182,571 | - |
| 236 | BEAM | Beam Therapeutics Inc. | 2.28B | -4.99% | 2,045,050 | 146.64M |
| 237 | CLDX | Celldex Therapeutics, Inc. | 2.26B | 1.05% | 544,313 | 158.00K |
| 238 | PRGO | Perrigo Company plc | 2.25B | 0.37% | 1,006,641 | 4.09B |
| 239 | ADUS | Addus HomeCare Corporation | 2.25B | -0.58% | 105,092 | 1.50B |
| 240 | PVLA | Palvella Therapeutics, Inc. | 2.23B | -0.46% | 241,726 | - |
| 241 | SDGR | Schrödinger, Inc. | 2.22B | -4.28% | 1,277,262 | 269.20M |
| 242 | IMNM | Immunome, Inc. | 2.22B | 0.37% | 951,064 | 4.02M |
| 243 | BKD | Brookdale Senior Living Inc. | 2.19B | 2.34% | 12,337,342 | 2.86B |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.19B | 1.92% | 500,439 | 1.17B |
| 245 | ALMR | Alamar Biosciences, Inc. | 2.14B | -2.99% | 667,710 | 114.05M |
| 246 | LKFT | Lakefront Biotherapeutics NV | 2.13B | 0.15% | 287,836 | 1.13B |
| 247 | ESTA | Establishment Labs Holdings Inc. | 2.11B | 3.10% | 367,354 | 264.03M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -2.96% | 691,247 | 321.74M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.10B | -2.24% | 1,300,546 | 1.08B |
| 250 | BHVN | Biohaven Ltd. | 2.09B | -1.78% | 1,257,764 | - |
| 251 | REPL | Replimune Group, Inc. | 2.08B | -0.41% | 2,020,646 | - |
| 252 | NEO | NeoGenomics, Inc. | 2.07B | -3.14% | 2,217,573 | 787.75M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.03B | -3.24% | 1,013,532 | 10.28M |
| 254 | SEPN | Septerna, Inc. | 2.03B | 1.77% | 337,793 | 96.27M |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 1.99B | -4.35% | 16,719,541 | 68.23M |
| 256 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.12% | 844,885 | 989.36M |
| 257 | TRAX | First Tracks Biotherapeutics, Inc. | 1.98B | -3.29% | 461,930 | - |
| 258 | VCYT | Veracyte, Inc. | 1.96B | -1.22% | 2,029,304 | 581.78M |
| 259 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.96B | -1.82% | 1,992,204 | 213.00M |
| 260 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.96B | -0.91% | 2,315,721 | 961.51M |
| 261 | FTRE | Fortrea Holdings Inc. | 1.95B | 0.70% | 1,964,979 | 2.67B |
| 262 | TRVI | Trevi Therapeutics, Inc. | 1.95B | 0.22% | 1,099,900 | - |
| 263 | AGL | agilon health, inc. | 1.94B | 4.86% | 152,538 | 6.00B |
| 264 | COAG | Hemab Therapeutics Holdings, Inc. | 1.91B | 3.76% | 401,087 | - |
| 265 | AZTA | Azenta, Inc. | 1.91B | 4.08% | 1,114,038 | 621.70M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 1.90B | 1.34% | 304,817 | 11.00M |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | -0.54% | 371,332 | 140.84M |
| 268 | MAZE | Maze Therapeutics, Inc. | 1.88B | -4.88% | 1,372,720 | 20.00M |
| 269 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | 4.04% | 601,199 | 141.06M |
| 270 | XRAY | DENTSPLY SIRONA Inc. | 1.82B | -0.87% | 4,028,966 | 3.58B |
| 271 | ZYME | Zymeworks Inc. | 1.81B | -0.87% | 770,307 | 265.97M |
| 272 | LYCA | Lycia Therapeutics, Inc. | 1.80B | -4.96% | 189,539 | 4.44M |
| 273 | LMAT | LeMaitre Vascular, Inc. | 1.79B | 0.82% | 200,050 | 269.36M |
| 274 | INSP | Inspire Medical Systems, Inc. | 1.77B | 0.93% | 574,397 | 880.94M |
| 275 | CERT | Certara, Inc. | 1.76B | -2.77% | 2,672,856 | 425.76M |
| 276 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.83% | 420,232 | 28.21M |
| 277 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 0.37% | 1,324,990 | 1.96B |
| 278 | KLRA | Kailera Therapeutics, Inc. | 1.72B | 0.45% | 566,966 | - |
| 279 | VIR | Vir Biotechnology, Inc. | 1.71B | -17.82% | 16,660,529 | 302.80M |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.71B | 0.07% | 343,482 | 106.73M |
| 281 | PSNL | Personalis, Inc. | 1.70B | -0.95% | 2,803,801 | 80.77M |
| 282 | MESO | Mesoblast Limited | 1.70B | 1.30% | 347,014 | 120.25M |
| 283 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -0.77% | 1,386,535 | 701.94M |
| 284 | HCSG | Healthcare Services Group, Inc. | 1.68B | -0.48% | 274,960 | 1.88B |
| 285 | QURE | uniQure N.V. | 1.67B | -3.33% | 1,394,445 | 20.17M |
| 286 | WWB | Windward Bio Group AG | 1.65B | 67.65% | 1,276,858 | - |
| 287 | RARE | Ultragenyx Pharmaceutical Inc. | 1.63B | -1.17% | 1,679,423 | 730.00M |
| 288 | ASTH | Astrana Health, Inc. | 1.63B | 0.09% | 297,201 | 3.91B |
| 289 | PGEN | Precigen, Inc. | 1.63B | -2.58% | 3,777,110 | 156.94M |
| 290 | BFLY | Butterfly Network, Inc. | 1.63B | -8.85% | 4,328,762 | 123.26M |
| 291 | OMCL | Omnicell, Inc. | 1.61B | 0.23% | 313,236 | 1.24B |
| 292 | TDOC | Teladoc Health, Inc. | 1.60B | 1.27% | 3,158,264 | 2.47B |
| 293 | SLS | SELLAS Life Sciences Group, Inc. | 1.60B | -2.12% | 11,201,572 | - |
| 294 | BRVE | Braveheart Bio, Inc. | 1.60B | -4.29% | 536,604 | - |
| 295 | SNDA | Sonida Senior Living, Inc. | 1.60B | -0.48% | 298,935 | 593.56M |
| 296 | ENOV | Enovis Corporation | 1.60B | 0.14% | 1,205,418 | 2.31B |
| 297 | ADRX | ADARx Pharmaceuticals, Inc. | 1.59B | -4.76% | 587,958 | 6.13M |
| 298 | WGS | GeneDx Holdings Corp. | 1.57B | 0.96% | 1,123,560 | 460.78M |
| 299 | NBTX | Nanobiotix S.A. | 1.56B | -4.95% | 93,102 | 13.15M |
| 300 | GENB | Generate Biomedicines, Inc. | 1.56B | -3.98% | 811,267 | 21.07M |
| 301 | RAPP | Rapport Therapeutics, Inc. | 1.55B | 1.16% | 316,028 | 20.00M |
| 302 | IMCR | Immunocore Holdings plc | 1.55B | -1.77% | 270,294 | 429.30M |
| 303 | ALHC | Alignment Healthcare, Inc. | 1.54B | -1.87% | 2,724,401 | 4.94B |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | 0.53% | 383,855 | 1.04B |
| 305 | CNMD | CONMED Corporation | 1.51B | 0.22% | 189,711 | 1.37B |
| 306 | ALVO | Alvotech | 1.50B | -10.28% | 2,091,318 | 492.31M |
| 307 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 1.01% | 148,432 | 829.86M |
| 308 | AMN | AMN Healthcare Services, Inc. | 1.47B | 1.60% | 575,637 | 3.52B |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.00% | 1,945,413 | 743.30M |
| 310 | PAHC | Phibro Animal Health Corporation | 1.46B | 1.44% | 293,911 | 1.54B |
| 311 | ABSI | Absci Corporation | 1.46B | -7.55% | 5,485,311 | 1.49M |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.44B | 1.18% | 225,508 | - |
| 313 | GPCR | Structure Therapeutics Inc. | 1.43B | 0.81% | 1,346,421 | - |
| 314 | LMRI | Lumexa Imaging Holdings, Inc. | 1.42B | -0.87% | 263,446 | 1.06B |
| 315 | NUVB | Nuvation Bio Inc. | 1.41B | -1.72% | 3,086,929 | 201.73M |
| 316 | NVAX | Novavax, Inc. | 1.41B | -2.68% | 4,643,002 | 411.65M |
| 317 | TNDM | Tandem Diabetes Care, Inc. | 1.40B | 14.62% | 4,396,778 | 1.08B |
| 318 | LBRX | LB Pharmaceuticals Inc | 1.39B | 1.30% | 330,168 | - |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.38B | 1.29% | 375,086 | - |
| 320 | NVCR | NovoCure Limited | 1.38B | 0.94% | 1,051,730 | 725.39M |
| 321 | ANAB | AnaptysBio, Inc. | 1.38B | -3.18% | 499,637 | 60.04M |
| 322 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | 1.23% | 1,677,806 | 352.31M |
| 323 | OCUL | Ocular Therapeutix, Inc. | 1.37B | -1.11% | 2,488,600 | 50.38M |
| 324 | NTLA | Intellia Therapeutics, Inc. | 1.36B | -8.06% | 11,416,703 | 52.89M |
| 325 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | -1.10% | 1,308,462 | - |
| 326 | INVA | Innoviva, Inc. | 1.35B | 0.32% | 560,886 | 438.32M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.35B | -1.01% | 574,889 | - |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.34B | -2.04% | 475,266 | - |
| 329 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | -2.61% | 2,474,554 | 5.49M |
| 330 | MNKD | MannKind Corporation | 1.33B | -0.72% | 1,686,713 | 413.37M |
| 331 | STAA | STAAR Surgical Company | 1.32B | -1.46% | 370,141 | 328.27M |
| 332 | AAPG | Ascentage Pharma Group International | 1.32B | -2.66% | 8,735 | 94.61M |
| 333 | GHRS | GH Research PLC | 1.31B | 3.30% | 560,158 | - |
| 334 | KARD | Kardigan, Inc. | 1.29B | -2.12% | 410,885 | - |
| 335 | INNV | InnovAge Holding Corp. | 1.29B | 0.74% | 334,451 | 1.02B |
| 336 | URGN | UroGen Pharma Ltd. | 1.28B | -0.80% | 700,012 | 250.25M |
| 337 | CMPS | COMPASS Pathways plc | 1.28B | -1.21% | 2,645,091 | - |
| 338 | NKTR | Nektar Therapeutics | 1.27B | 0.05% | 695,165 | 52.19M |
| 339 | PNTG | The Pennant Group, Inc. | 1.27B | 0.45% | 419,991 | 1.17B |
| 340 | OMER | Omeros Corporation | 1.27B | -2.78% | 737,383 | 38.42M |
| 341 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.25B | 1.73% | 380,761 | 745.79M |
| 342 | SVRA | Savara Inc. | 1.25B | -1.69% | 3,231,765 | - |
| 343 | OPK | OPKO Health, Inc. | 1.25B | 0.60% | 2,137,837 | 654.10M |
| 344 | CRON | Cronos Group Inc. | 1.24B | -0.88% | 722,861 | 206.20M |
| 345 | DRTS | Alpha Tau Medical Ltd. | 1.24B | 0.15% | 404,629 | - |
| 346 | SLN | Silence Therapeutics plc | 1.23B | 0.15% | 586,516 | 456.00K |
| 347 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -5.07% | 245,896 | 2.00M |
| 348 | GDRX | GoodRx Holdings, Inc. | 1.21B | 1.42% | 788,255 | 785.23M |
| 349 | VOR | Vor Biopharma Inc. | 1.19B | 0.52% | 739,307 | - |
| 350 | NUTX | Nutex Health Inc. | 1.19B | 1.32% | 79,867 | 796.53M |
| 351 | ANRO | Alto Neuroscience, Inc. | 1.18B | -3.53% | 610,927 | - |
| 352 | HROW | Harrow, Inc. | 1.13B | 6.43% | 736,350 | 303.25M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.12B | 0.35% | 648,838 | 1.66B |
| 354 | FRNM | Freenome, Inc. | 1.12B | -1.89% | 615,402 | 217.86M |
| 355 | JBIO | Jade Biosciences, Inc. | 1.12B | 1.70% | 593,498 | - |
| 356 | SGP | SpyGlass Pharma, Inc. | 1.10B | -1.32% | 39,455 | - |
| 357 | ATEC | Alphatec Holdings, Inc. | 1.10B | 0.14% | 3,531,308 | 839.72M |
| 358 | IRMD | IRADIMED CORPORATION | 1.09B | 0.38% | 115,214 | 89.34M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -0.75% | 346,855 | - |
| 360 | MLTX | MoonLake Immunotherapeutics | 1.06B | -2.87% | 1,190,709 | - |
| 361 | AHG | Akso Health Group | 1.06B | -7.81% | 2,564 | 13.83M |
| 362 | SIBN | SI-BONE, Inc. | 1.06B | -2.90% | 443,690 | 220.65M |
| 363 | GMRS | GMR Solutions Inc. | 1.04B | 2.12% | 1,692,439 | 5.97B |
| 364 | CSTL | Castle Biosciences, Inc. | 1.04B | -2.06% | 347,750 | 377.13M |
| 365 | VSTM | Verastem, Inc. | 1.03B | -3.08% | 1,721,342 | 100.30M |
| 366 | AHCO | AdaptHealth Corp. | 1.02B | -2.67% | 2,188,130 | 3.44B |
| 367 | CBLL | CeriBell, Inc. | 1.02B | -0.80% | 267,633 | 108.72M |
| 368 | AORT | Artivion, Inc. | 931.88M | -1.55% | 558,000 | 481.88M |
| 369 | AKTS | Aktis Oncology, Inc. | 927.36M | 2.09% | 244,542 | 12.39M |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 917.59M | -4.78% | 322,921 | 99.00K |
| 371 | CTY | City Therapeutics, Inc. | 900.60M | -4.64% | 482,372 | 14.34M |
| 372 | BVS | Bioventus Inc. | 898.22M | -1.84% | 650,633 | 585.64M |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 897.52M | 0.19% | 625,297 | - |
| 374 | MGTX | MeiraGTx Holdings plc | 897.17M | 4.44% | 732,221 | 401.91M |
| 375 | BBNX | Beta Bionics, Inc. | 892.71M | -0.55% | 1,095,378 | 127.27M |
| 376 | PHAR | Pharming Group N.V. | 891.17M | -2.70% | 5,072 | 386.75M |
| 377 | OMDA | Omada Health, Inc. | 889.00M | -2.52% | 1,205,333 | 333.04M |
| 378 | IVA | Inventiva S.A. | 883.90M | -5.15% | 3,316,485 | 2.81M |
| 379 | IMTX | Immatics N.V. | 873.45M | -1.99% | 586,386 | 49.33M |
| 380 | LTGO | Latigo Biotherapeutics, Inc. | 869.18M | 1.39% | 406,524 | - |
| 381 | HSTM | HealthStream, Inc. | 856.80M | -1.13% | 176,210 | 327.95M |
| 382 | SNDX | Syndax Pharmaceuticals, Inc. | 850.77M | -0.94% | 3,179,737 | 289.68M |
| 383 | KIDS | OrthoPediatrics Corp. | 844.67M | -0.71% | 114,273 | 264.14M |
| 384 | RIGL | Rigel Pharmaceuticals, Inc. | 837.18M | -2.69% | 151,587 | 288.21M |
| 385 | BBTX | Bambusa Therapeutics, Inc. | 819.66M | -3.94% | 384,619 | - |
| 386 | ORIC | ORIC Pharmaceuticals, Inc. | 814.71M | -7.53% | 1,008,697 | - |
| 387 | GLUE | Monte Rosa Therapeutics, Inc. | 800.67M | 0.64% | 1,119,299 | 70.33M |
| 388 | IRWD | Ironwood Pharmaceuticals, Inc. | 799.61M | -0.41% | 2,808,074 | 400.30M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 796.97M | -1.65% | 1,893,364 | 38.54M |
| 390 | PHR | Phreesia, Inc. | 787.68M | 0.55% | 459,484 | 507.79M |
| 391 | COLL | Collegium Pharmaceutical, Inc. | 786.83M | 1.48% | 395,541 | 815.19M |
| 392 | ARDX | Ardelyx, Inc. | 776.74M | -0.96% | 2,380,472 | 468.22M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 775.87M | 0.64% | 314,041 | - |
| 394 | CTKB | Cytek Biosciences, Inc. | 763.78M | 5.80% | 1,280,258 | 207.65M |
| 395 | SLDB | Solid Biosciences Inc. | 763.42M | -2.29% | 975,452 | - |
| 396 | VREX | Varex Imaging Corporation | 762.88M | -0.93% | 798,830 | 865.00M |
| 397 | INMD | InMode Ltd. | 762.77M | 0.61% | 566,370 | 373.60M |
| 398 | PRME | Prime Medicine, Inc. | 761.98M | 9.77% | 5,964,356 | 7.06M |
| 399 | ANNX | Annexon, Inc. | 747.79M | -1.26% | 2,585,706 | - |
| 400 | AURA | Aura Biosciences, Inc. | 739.97M | 0.00% | 610,303 | - |
| 401 | QDEL | QuidelOrtho Corporation | 736.90M | 1.13% | 2,037,427 | 2.59B |
| 402 | SGMT | Sagimet Biosciences Inc. | 729.38M | -6.50% | 759,442 | - |
| 403 | ALMS | Alumis Inc. | 727.00M | -8.65% | 1,492,368 | 7.24M |
| 404 | OABI | OmniAb, Inc. | 716.17M | -0.81% | 852,291 | 40.21M |
| 405 | DCTH | Delcath Systems, Inc. | 714.89M | -3.88% | 675,133 | 109.96M |
| 406 | KURA | Kura Oncology, Inc. | 713.90M | 4.58% | 2,227,255 | 79.31M |
| 407 | APMD | Apnimed, Inc. | 704.39M | 1.74% | 690,802 | 115.12M |
| 408 | SOPH | SOPHiA GENETICS SA | 703.25M | 4.45% | 623,053 | 90.97M |
| 409 | NVCT | Nuvectis Pharma, Inc. | 696.03M | 0.05% | 208,982 | - |
| 410 | JANX | Janux Therapeutics, Inc. | 695.66M | -1.13% | 717,849 | 23.29M |
| 411 | ATTO | Attovia Therapeutics, Inc. | 690.70M | -4.30% | 322,873 | 1.44M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 689.52M | 0.91% | 813,800 | 96.06M |
| 413 | FLGT | Fulgent Genetics, Inc. | 688.98M | -0.76% | 262,094 | 330.28M |
| 414 | ANL | Adlai Nortye Group Ltd. | 683.26M | 0.86% | 152,055 | 18.06M |
| 415 | DBVT | DBV Technologies S.A. | 682.01M | -3.63% | 278,931 | 3.74M |
| 416 | AVBP | ArriVent BioPharma, Inc. | 672.92M | -0.46% | 616,142 | 5.00M |
| 417 | DSGN | Design Therapeutics, Inc. | 670.46M | -1.04% | 238,449 | - |
| 418 | CGEM | Cullinan Therapeutics, Inc. | 667.39M | 0.88% | 1,376,933 | - |
| 419 | BCAX | Bicara Therapeutics Inc. | 665.20M | -0.89% | 1,519,596 | - |
| 420 | OLMA | Olema Pharmaceuticals, Inc. | 662.30M | 0.53% | 1,696,511 | - |
| 421 | IMMX | Immix Biopharma, Inc. | 657.09M | -2.85% | 1,027,812 | - |
| 422 | HELP | Helus Pharma Inc. | 648.04M | 0.11% | 979,145 | - |
| 423 | ABUS | Arbutus Biopharma Corporation | 626.97M | 1.49% | 3,311,219 | 181.49M |
| 424 | GERN | Geron Corporation | 622.98M | -2.72% | 7,099,034 | 217.52M |
| 425 | DNA | Ginkgo Bioworks Holdings, Inc. | 622.89M | -6.06% | 1,860,373 | 130.75M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 621.76M | -2.00% | 1,146,661 | 6.40M |
| 427 | IAM | Iambic Therapeutics, Inc. | 620.95M | -11.73% | 277,980 | 18.25M |
| 428 | WVE | Wave Life Sciences, Inc. | 617.33M | -0.79% | 2,660,111 | 70.92M |
| 429 | PACB | Pacific Biosciences of California, Inc. | 613.34M | -0.51% | 7,020,617 | 161.39M |
| 430 | CLYM | Climb Bio, Inc. | 608.53M | -4.69% | 667,804 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 605.64M | -1.53% | 284,754 | 15.00M |
| 432 | SANA | Sana Biotechnology, Inc. | 605.26M | 0.50% | 3,201,187 | - |
| 433 | SRZN | Surrozen, Inc. | 602.54M | -0.19% | 106,701 | 10.53M |
| 434 | SGHT | Sight Sciences, Inc. | 601.92M | -1.46% | 223,726 | 88.40M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 600.58M | -0.04% | 169,916 | 356.42M |
| 436 | EVO | Evotec SE | 581.78M | -4.82% | 46,512 | 815.72M |
| 437 | SENS | Senseonics Holdings, Inc. | 579.58M | 5.38% | 1,120,690 | 60.01M |
| 438 | OBIO | Orchestra BioMed Holdings, Inc. | 570.61M | 17.89% | 1,567,673 | 31.21M |
| 439 | NRC | NRC Health | 563.64M | -0.30% | 116,540 | 143.79M |
| 440 | ETRA | Electra Therapeutics, Inc. | 554.86M | -2.96% | 313,057 | - |
| 441 | EVH | Evolent Health, Inc. | 554.22M | 2.73% | 1,334,052 | 2.34B |
| 442 | CAPR | Capricor Therapeutics, Inc. | 554.09M | -6.93% | 3,666,024 | 11.13M |
| 443 | MYGN | Myriad Genetics, Inc. | 542.92M | -0.35% | 1,051,779 | 803.60M |
| 444 | ENTX | Entera Bio Ltd. | 541.57M | -3.42% | 155,334 | 42.00K |
| 445 | ZVRA | Zevra Therapeutics, Inc. | 540.30M | -18.64% | 2,941,991 | 147.76M |
| 446 | VALN | Valneva SE | 539.15M | -1.74% | 2,719 | 163.30M |
| 447 | EPRX | Eupraxia Pharmaceuticals Inc. | 538.75M | 4.35% | 777,239 | - |
| 448 | AVR | Anteris Technologies Global Corp. | 528.41M | -7.51% | 1,471,125 | 2.33M |
| 449 | TKNO | Alpha Teknova, Inc. | 516.43M | -1.08% | 416,654 | 45.95M |
| 450 | RGNX | REGENXBIO Inc. | 505.18M | -4.86% | 716,115 | 153.91M |
| 451 | ANGO | AngioDynamics, Inc. | 499.19M | -1.00% | 280,800 | 325.38M |
| 452 | NGNE | Neurogene Inc. | 495.37M | 0.13% | 193,615 | 925.00K |
| 453 | SRTA | Strata Critical Medical, Inc. | 492.15M | -4.51% | 874,569 | 280.76M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 491.44M | 9.52% | 3,966,973 | 48.84M |
| 455 | RCEL | AVITA Medical, Inc. | 491.10M | -3.52% | 497,278 | 84.68M |
| 456 | MNPR | Monopar Therapeutics Inc. | 487.93M | -0.94% | 203,862 | - |
| 457 | INDP | Indaptus Therapeutics, Inc. | 486.85M | 0.63% | 113,195 | - |
| 458 | CADL | Candel Therapeutics, Inc. | 486.36M | -26.10% | 6,622,128 | - |
| 459 | PHAT | Phathom Pharmaceuticals, Inc. | 481.35M | -2.73% | 1,509,710 | 274.88M |
| 460 | OVID | Ovid Therapeutics Inc. | 479.38M | -0.39% | 2,901,558 | 1.45M |
| 461 | DMAC | DiaMedica Therapeutics Inc. | 474.29M | -5.79% | 214,090 | - |
| 462 | STTK | Shattuck Labs, Inc. | 473.57M | -3.33% | 775,896 | 1.00M |
| 463 | GYRE | Gyre Therapeutics, Inc. | 471.74M | 0.23% | 281,341 | 110.06M |
| 464 | OCS | Oculis Holding AG | 471.63M | 1.87% | 183,973 | 1.12M |
| 465 | KMDA | Kamada Ltd. | 470.78M | -0.49% | 94,468 | 196.87M |
| 466 | CARL | Carlsmed, Inc. | 469.16M | -1.04% | 219,598 | 71.78M |
| 467 | MDXG | MiMedx Group, Inc. | 468.42M | -0.93% | 1,127,509 | 303.73M |
| 468 | EOLS | Evolus, Inc. | 460.67M | -3.06% | 455,367 | 325.47M |
| 469 | CTEV | Claritev Corporation | 457.95M | -0.30% | 175,322 | 1.02B |
| 470 | RLMD | Relmada Therapeutics, Inc. | 449.19M | 1.20% | 1,736,265 | - |
| 471 | AVTX | Avalo Therapeutics, Inc. | 448.71M | 0.78% | 974,224 | 59.00K |
| 472 | ARVN | Arvinas, Inc. | 446.61M | -0.73% | 879,352 | 275.30M |
| 473 | BLSM | BlossomHill Therapeutics, Inc. | 445.62M | -5.53% | 222,586 | - |
| 474 | CTMX | CytomX Therapeutics, Inc. | 444.73M | 0.00% | 2,724,695 | 14.03M |
| 475 | MOBI | Mobia Medical, Inc. | 438.93M | -1.05% | 160,568 | 51.89M |
| 476 | SI | Shoulder Innovations, Inc. | 432.89M | -1.85% | 247,821 | 64.49M |
| 477 | ASMB | Assembly Biosciences, Inc. | 432.48M | 4.66% | 318,848 | 67.01M |
| 478 | PRTA | Prothena Corporation plc | 419.01M | -0.85% | 340,447 | 52.74M |
| 479 | SLBT | SL Science Holding Limited | 414.58M | -4.88% | 25,230 | 3.27M |
| 480 | TECX | Tectonic Therapeutic, Inc. | 413.27M | 0.48% | 300,637 | - |
| 481 | FENC | Fennec Pharmaceuticals Inc. | 410.25M | 6.61% | 461,083 | 66.37M |
| 482 | BWAY | BrainsWay Ltd. | 406.86M | -1.37% | 183,573 | 60.70M |
| 483 | MASS | 908 Devices Inc. | 405.01M | -0.51% | 343,976 | 65.79M |
| 484 | MPLT | MapLight Therapeutics, Inc. | 402.92M | 2.55% | 367,746 | - |
| 485 | PBYI | Puma Biotechnology, Inc. | 401.70M | -3.84% | 403,673 | 231.83M |
| 486 | CERS | Cerus Corporation | 400.88M | 2.32% | 1,821,439 | 226.57M |
| 487 | SPRY | ARS Pharmaceuticals, Inc. | 391.06M | 2.10% | 1,297,296 | 122.14M |
| 488 | CTNM | Contineum Therapeutics, Inc. | 387.16M | 0.82% | 265,893 | - |
| 489 | IRD | Opus Genetics, Inc. | 384.68M | -1.97% | 747,200 | 7.91M |
| 490 | RZLT | Rezolute, Inc. | 383.42M | -5.56% | 5,736,194 | - |
| 491 | ALEC | Alector, Inc. | 378.15M | 3.67% | 1,799,091 | 173.47M |
| 492 | CRMD | CorMedix Inc. | 370.65M | -3.72% | 2,391,240 | 412.49M |
| 493 | TRXB | TRex Bio, Inc. | 368.02M | -3.05% | 62,667 | - |
| 494 | ASPE | Aspen Neuroscience, Inc. | 366.10M | -7.49% | 173,574 | - |
| 495 | EMBC | Embecta Corp. | 366.02M | 0.47% | 566,841 | 1.02B |
| 496 | CCCC | C4 Therapeutics, Inc. | 362.44M | -0.36% | 2,543,574 | 32.28M |
| 497 | STLN | Starling Oncology, Inc. | 356.97M | -6.67% | 23,018,194 | 620.45M |
| 498 | TLRY | Tilray Brands, Inc. | 356.39M | -2.41% | 2,553,950 | 963.10M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 355.33M | -1.99% | 262,091 | 22.42M |
| 500 | LYEL | Lyell Immunopharma, Inc. | 351.57M | -8.57% | 236,615 | 15.00K |